# Treatment of Refractory Status Epilepticus

> **NCT00265616** · PHASE3 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 23 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** propofol
- **DRUG:** thiopental/pentobarbital

## Key facts

- **NCT ID:** NCT00265616
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265616, "Treatment of Refractory Status Epilepticus". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00265616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*